LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Vantiv, Moody’s, Cintas, and Ritchie Bros. Auctioneers.

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/.

Following their last close on Friday, May 20, 2016, ActiveWallSt.com takes a brief technical look at how each of the companies mentioned above have performed over the course of the last few trading days. To receive your complimentary technical alerts, click below:

http://www.activewallst.com/

Vantiv Inc. (NYSE: VNTV)

Last Friday at the close, shares in Vantiv Inc., which offers electronic payment processing services to merchants and financial institutions in the U.S., ended the trading session at $53.12 that is a slight correction of 0.65%. The stock recorded a trading volume of 1.97 million shares, above its three months average volume of 1.44 million shares. The Company’s shares have advanced 3.59% in the previous three months and 12.02% since the start of this year. The stock is trading above its 200-day moving average by 7.93%. Furthermore, shares of Vantiv have a Relative Strength Index (RSI) of 39.05.

Moody’s Corp. (NYSE: MCO)

Credit ratings firm Moody’s Corp.’s stock finished Friday’s session 0.82% higher at $93.83 with a total volume of 832,767 shares traded. The Company’s shares have advanced 6.90% over the previous three months. The stock is trading slightly below its 50-day moving average by 1.64%. Additionally, shares of Moody’s have an RSI of 45.70.

Cintas Corp. (NASDAQ: CTAS)

Shares in Cincinnati, Ohio-based Company, Cintas Corp., ended the session 0.69% higher at $92.05. A total volume of 1.03 million shares was traded, above their three months average volume of 633,950 shares. The stock has advanced 3.24% in the past month, 8.75% in the previous three months, and 1.10% since the start of this year. The Company’s shares are trading above their 50-day and 200-day moving averages by 2.40% and 4.60%, respectively. Moreover, shares of Cintas have an RSI of 66.31.

Ritchie Bros. Auctioneers Inc. (NYSE: RBA)

British Columbia-based Company Ritchie Bros. Auctioneers Inc.’s stock recorded a trading volume of 264,515 shares on Friday, and closed 0.19% lower at $31.89. The Company’s shares have gained 11.19% in the past month, 38.71% over the previous three months, and 33.17% on an YTD basis. The stock is trading 13.60% above its 50-day moving average and 23.48% above its 200-day moving average. Additionally, shares of Ritchie Bros. Auctioneers have an RSI of 74.28. RBA free technical alert is just a click away at:

http://www.activewallst.com/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.activewallst.com.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: ActiveWallStreet.com

ReleaseID: 440292

LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include bluebird bio, Nektar Therapeutics, Sequenom, and Tesaro.

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/.

The Biotechnology industry continues to face headwinds, but investors still can find good trading opportunities within this space. Let us see how this is affecting some of the big names in the industry. Sign up now at:

http://www.activewallst.com/

Let us take a brief technical look at how each company mentioned above has fared over the last few trading sessions.

bluebird bio Inc. (NASDAQ: BLUE)

Clinical-stage Biotechnology Company bluebird bio Inc.’s stock surged 4.56%, finishing last Friday’s session at $40.60 with a total volume of 587,366 shares traded. The Company’s shares are trading below their 50-day moving average by 8.28%. The stock has a Relative Strength Index (RSI) of 48.12.

Nektar Therapeutics (NASDAQ: NKTR)

On Friday, shares in Biotech Company, Nektar Therapeutics, ended the session 3.36% higher at $13.84. The stock recorded a trading volume of 844,150 shares. The Company’s shares have gained 20.35% in the previous three months. The stock is trading above its 200-day moving average by 4.94%. Moreover, shares of Nektar Therapeutics have an RSI of 48.18.

Sequenom Inc. (NASDAQ: SQNM)

Life sciences Company Sequenom Inc.’s stock saw a slight correction of 0.94%, to close the day at $1.05 with a total volume of 525,165 shares traded. The Company, which develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the U.S. and globally, saw its stock trade 22.12% below its 50-day moving average. The stock has an RSI of 32.23.

Tesaro Inc. (NASDAQ: TSRO)

Shares in oncology-focused biopharma Company, Tesaro Inc., recorded a trading volume of 729,742 shares on Friday, which was higher than their three months average volume of 595,390 shares. The stock ended the trading session at $43.11, gaining 0.26%. The Company’s shares have advanced 9.47% in the previous three months and are trading below their 50-day moving average by 1.57%. Furthermore, shares of the Tesaro have an RSI of 50.15. Trade alert on TSRO is available for free at:

http://www.activewallst.com/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.activewallst.com.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: ActiveWallStreet.com

ReleaseID: 440289

LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Ameriprise Financial, T. Rowe Price, Federated Investors, and Carlyle.

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/

Below is a brief technical review of these stocks’ performances at their close. Join us now and activate the free technical alerts on these stocks at:

http://www.activewallst.com/

Ameriprise Financial Inc. (NYSE: AMP)

Financial products and services provider Ameriprise Financial Inc.’s stock finished last Friday’s session 1.10% higher at $97.67. A total volume of 883,140 shares was traded. The Company’s shares have advanced 16.45% in the previous three months. The stock is trading above its 50-day moving average by 3.65%. Additionally, shares of Ameriprise Financial have a Relative Strength Index (RSI) of 57.80.

T. Rowe Price Group Inc. (NASDAQ: TROW)

On Friday, shares in asset management holding company, T. Rowe Price Group Inc., ended the session 1.55% higher at $74.88. The stock recorded a trading volume of 3.99 million shares, higher than its three months average volume of 1.37 million shares. The Company’s shares have gained 7.94% in the previous three months and 5.53% on an YTD basis. The stock is trading 0.66% above its 50-day moving average and 4.75% above its 200-day moving average. Moreover, shares of T. Rowe Price Group have an RSI of 49.50.

Federated Investors Inc. (NYSE: FII)

Asset management holding company Federated Investors Inc.’s stock gained 1.74%, closing the session at $31.55 with a total volume of 558,242 shares traded. The Company’s shares have gained 1.46% in the last one month, 25.23% over the previous three months, and 12.21% since the start of this year. The stock is trading 6.32% and 9.70% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Federated Investors have an RSI of 60.19.

The Carlyle Group L.P. (NASDAQ: CG)

On Friday, shares in investment firm The Carlyle Group L.P. recorded a trading volume of 304,173 shares, and ended the day 2.52% higher at $16.29. The stock has advanced 7.72% over the previous three months and 8.13% on an YTD basis. The Company’s shares are trading below their 50-day moving average by 0.57%. Furthermore, shares of The Carlyle Group have an RSI of 51.19. The complete technical setup on CG is available for free at:

http://www.activewallst.com/

—

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.activewallst.com

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: ActiveWallSt.com

ReleaseID: 440295

LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include KeyCorp, Huntington Bancshares, Fifth Third Bancorp, and U.S. Bancorp.

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/.

The Regional Midwest Banking industry is once again on the growth path, with several stocks showing signs of improvement. Let us see how this is affecting some of the big names in the industry. Register now for free access at:

http://www.activewallst.com/

Here are this morning’s features companies and how each has performed of late:

KeyCorp (NYSE: KEY)

Last Friday, shares in KeyCorp, which operates as the bank holding company for KeyBank National Association, ended the session 0.73% higher at $12.48. The stock recorded a trading volume of 9.11 million shares. The Company’s shares have advanced 1.55% in the last month and 14.99% over the previous three months. The stock is trading 7.39% above its 50-day moving average and 1.34% above its 200-day moving average. Moreover, shares of KeyCorp have a Relative Strength Index (RSI) of 60.96.

Huntington Bancshares Inc. (NASDAQ: HBAN)

Huntington Bancshares Inc., which operates as a holding company for The Huntington National Bank, saw its shares gained 0.10% to close Friday’s session at $10.23. The stock recorded a trading volume of 8.45 million shares. The Company’s shares have advanced 0.10% in the past month and 16.57% in the previous three months. The stock is trading 4.33% above its 50-day moving average and 0.19% above its 200-day moving average. Additionally, shares of Huntington Bancshares have an RSI of 58.97.

Fifth Third Bancorp (NASDAQ: FITB)

Fifth Third Bancorp, which operates as a diversified financial services company in the United States, saw its stock end the day 0.77% higher at $18.28. Shares in regional bank recorded a trading volume of 6.98 million shares at the close of the last trading session. The Company’s shares have advanced 17.55% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 4.86% and 0.39%, respectively. Furthermore, shares of Fifth Third Bancorp have an RSI of 57.72.

U.S. Bancorp (NYSE: USB)

Financial services holding company U.S. Bancorp’s shares finished Friday’s session 0.53% higher at $41.74 with a total volume of 5.78 million shares traded. The Company, which offers a wide range of financial services in the U.S., saw its stock advanced 4.41% in the previous three months. The Company’s shares are trading above their 50-day and 200-day moving averages by 1.12% and 1.21%, respectively. Furthermore, shares of U.S. Bancorp have an RSI of 49.59. USB alerts are available for free at:

http://www.activewallst.com/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.activewallst.com.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: ActiveWallStreet.com

ReleaseID: 440288

LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include Chesapeake Energy, Marathon Oil, Southwestern Energy and California Resources.

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/.

Independent Oil and Gas stocks have suffered immensely since 2014, but industry experts are optimistic that the segment would see improvement by the end of this year. Let us see how this is affecting some of the big names in the industry. Access our technical insights at:

http://www.activewallst.com/

Let us take a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Chesapeake Energy Corp. (NYSE: CHK)

Last Friday, shares in Chesapeake Energy Corp. ended the day at $3.72, which was a correction of 3.63%. The stock recorded a trading volume of 39.10 million shares. The Company engages in the acquisition, exploration, and development of properties for the production of oil, natural gas, and natural gas liquids from underground reservoirs in the United States. The Company’s shares have advanced 55.65% in the previous three months. The stock is trading below its 50-day moving average by 24.79%. Furthermore, shares of Chesapeake Energy have a Relative Strength Index (RSI) of 31.92.

Marathon Oil Corp. (NYSE: MRO)

Energy Company Marathon Oil Corporation operates through three segments – North America Exploration and Production, International Exploration and Production, and Oil Sands Mining. The Company’s stock finished Friday’s session 2.90% higher at $13.11. A total volume of 17.17 million shares was traded. The Company’s shares have gained 75.75% in the previous three months and 5.30% since the start of this year. The stock is trading above its 50-day moving average by 8.04%. Moreover, shares of Marathon Oil have an RSI of 57.29.

Southwestern Energy Co. (NYSE: SWN)

Shares in Southwestern Energy Co., an independent exploration and production natural gas and oil company, which operates primarily in the United States, ended Friday’s session 3.32% lower at $11.65 with a total volume of 14.89 million shares traded. The stock has gained 9.18% in the last month, 60.47% over the previous three months, and 63.85% on an YTD basis. The Company’s shares are trading above their 50-day and 200-day moving averages by 15.87% and 10.66%, respectively. Moreover, Southwestern Energy’s stock has an RSI of 52.67.

California Resources Corp. (NYE: CRC)

Oil and natural gas exploration and production company California Resources Corp. which operates in the State of California saw its stock record a trading volume of 6.48 million shares last Friday. The stock closed the day 4.67% higher at $1.57. The Company’s shares have surged 257.63% over the previous three months. The stock is trading 1.63% below its 50-day moving average. Additionally, shares of California Resources have an RSI of 45.12. CRC free trade alert is just a click away at:

http://www.activewallst.com/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.activewallst.com.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: ActiveWallStreet.com

ReleaseID: 440297

LONDON, UK / ACCESSWIRE / May 23, 2016 / ActiveWallSt.com announces the list of stocks featured in the Technical Morning Blog. Every morning the Active Wall St. team discusses the latest news and technical events impacting stocks and the financial markets. Companies recently featured in the blog include: 21Vianet Group, CSRA Inc., CDW Corp., and Wipro. 

Today, ActiveWallSt.com is promoting its technical alert briefings. Get all of our alerts free by signing up to http://www.activewallst.com/

The Technology sector is rapidly advancing, which can be a double edge sword for firms in this space. Let us see how the cutthroat competition is affecting some of the big players in the key sector. Get started today by signing up for free at:

http://www.activewallst.com/

How each of the companies above has fared over the last few trading sessions is set below. Read through the brief technical review:

21Vianet Group Inc. (NASDAQ: VNET)

Shares in 21Vianet Group Inc., a provider of carrier-neutral Internet data center services, ended last Friday’s session at $14.45, which was a slight correction of 0.21%. A total volume of 1.78 million shares was traded, above their three months average volume of 1.16 million shares. The stock is trading 24.72% below its 50-day moving average. Moreover, shares of 21Vianet Group have a Relative Strength Index (RSI) of 32.20.

CSRA Inc. (NYSE: CSRA)

CSRA Inc. offers an array of IT solutions and professional services to U.S. government agencies and programs. The Company’s stock climbed 1.75%, closing the day at $25.01 with a total volume of 649,367 shares traded. The Company’s shares are trading 2.74% below their 50-day moving average. The stock has an RSI of 48.11.

CDW Corp. (NASDAQ: CDW)

Last Friday, shares in information technology services Company CDW Corp. gained 1.14%, closing the session at $42.69. The stock recorded a trading volume of 657,020 shares. The Company’s shares have advanced 1.21% in the last one month, 9.88% over the previous three months, and 1.83% on an YTD basis. The stock is trading 3.60% above its 50-day moving average and 4.44% above its 200-day moving average. Furthermore, shares of CDW have an RSI of 62.26.

Wipro Ltd (NYSE: WIT)

IT services provider Wipro Ltd’s shares finished the session 1.10% higher at $12.00 and with a total volume of 260,876 shares traded. The stock has advanced 3.90% in the previous three months and 4.66% since the start of this year. The Company’s shares are trading above their 200-day moving average by 0.74%. Additionally, shares of Wipro have an RSI of 47.11. Technical alert on WIT is available for free at:

http://www.activewallst.com/

—

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit www.activewallst.com

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: ActiveWallSt.com

ReleaseID: 440293

NEW YORK, NY / ACCESSWIRE / May 23, 2016 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on VolitionRx Ltd. (NYSE MKT: VNRX).

The note is available here: VNRX May 2016 Update Note. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

Highlights of note are as follows:

Significant progress since our initiation of research coverage

VNRX is currently developing blood-based cancer diagnostics tests initially targeting colorectal cancer (CRC) and planned expansion to pancreatic cancer, lung cancer, prostate cancer, endometriosis and other diseases. VNRX has made nice progress on the regulatory, clinical and corporate development fronts since we initiated coverage on the company in February 2015, with encouraging clinical results in a number of areas, as well as the company receiving CE Marking for two biomarker assays to detect the presence of colorectal cancer signatures (NuQ®V001, NuQ®T003).

Several upcoming potential milestones

We see several catalysts ahead for the company as it advances towards commercialization of NuQ® for CRC in Europe and continues therapeutic development from its family of 28 NuQ biomarker assays. Notably, management expects to have final data to report from its 4,800-patient retrospective colorectal symptomatic population trial by the end of 2016E, and expects to have validation data for up to 5,000 patients from its ongoing 14,000 subject prospective Danish CRC trial by the end of 2016E/ early 2017E. We believe the company is targeting mid-2017E for CE Marking for its pancreatic and lung NuQ® diagnostic tests. In the US the company is aiming to submit a 510(k) application with the FDA for NuQ® as an adjunct test for CRC that, if accepted, could enable the company to commence a commercial launch as early as EOY2017.

CE Marking for lead NuQ® assays for CRC

We were pleased to see the April announcement that two of VNRX’s biomarker assays for colorectal cancer (CRC) had received CE Marking (NuQ®V001, NuQ®T003). This is a major accomplishment for management, and enables VNRX to pursue commercialization activities in Europe. Europe represents a large potential market opportunity for VNRX’s CRC diagnostics, given that there are over 430,000 new CRC cases each year, and NuQ® is a simpler, more accurate, blood-based test with the potential to gain adoption among the approximately 145mn 50-74 year-olds in the 28 EU Member states.

New raise enables company to advance clinical program

Importantly, VNRX recently completed a $12.8mn equity raise in March, at $3.25 per share, which should provide the company with sufficient capital to advance its clinical program while still investing in commercialization activities for NuQ® for CRC in Europe. VNRX has six ongoing clinical trials with prospective NuQ® assays covering a number of therapeutic arears in addition to CRC, which would drastically expand its commercial market opportunity if approved by regulators, including: pancreatic cancer, lung cancer (1 trial), prostate cancer (2 trials), pan-cancer (1 trial testing 27 cancers) and endometriosis.

Maintaining price target of $6.70

We see VNRX as targeting a large and potentially transformative market in healthcare / biopharmaceutical space. If achieved, the price target of $6.70 represents upside potential of 95.9% from the recent price of $3.42.

Please review important disclosures at www.seethruequity.com.

About VolitionRx Ltd.

VolitionRx is a life sciences company focused on developing blood-based diagnostic tests for different types of cancer. The NuQ® tests are based on the science of Nucleosomics® which is the practice of identifying and measuring nucleosomes in the bloodstream – an indication that cancer is present.

VolitionRx’s goal is to make the tests as common and simple to use, for both patients and doctors, as existing diabetic and cholesterol blood tests. VolitionRx’s research and development activities are currently centered in Belgium as the company focuses on bringing its diagnostic products to market first in Europe, then in the U.S. and ultimately, worldwide. VolitionRx.com

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. The company does not conduct any investment banking or commission based business. SeeThruEquity is approved to contribute its research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks, and distribute its research to its database of opt-in investors. The company also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 440301

NEW YORK, NY / ACCESSWIRE / May 23, 2016 / SeeThruEquity, a leading New York City based independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued an update note on Innovus Pharmaceuticals, Inc. (OTCQB: INNV).

The note is available here: INNV May 2016 Update Note. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack’s. The report will be available on these platforms. The firm also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

Innovus Pharmaceuticals, Inc. (OTCBB: INNV, “Innovus”) is an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter (OTC) medicine and consumer care products to improve men and women’s health, respiratory disease and vitality. Innovus recently released 1Q16 results, which showed double-digit organic growth as well as controlled operating expenses. The company recently completed the acquisition of Beyond Human™, which has expanded its pipeline to include 13 commercialized products and three pipeline products, and has several upcoming key milestones on the horizon, including:

• Fluticare™: Innovus management expects to hear from the FDA regarding its ANDA for Fluticare™, which is perhaps the crown jewel of the company’s pipeline, targeting what Innovus estimates is a $1Bn potential opportunity.
• Strong Outlook: Innovus has stated that it expects to more than triple FY15 sales in FY16, with the rise driven by a combination of growth in its commercial products and the inclusion of Beyond Human™ in results.
• Innovus continues to target an uplisting to a national exchange, likely the NYSE Market – a goal reiterated by management in an announcement by the company on May 17, 21016.

Highlights of note are as follows:

FlutiCare™ decision a significant catalyst

Innovus management expects to hear from the FDA within the next 3-4 months regarding its significant pipeline product, FlutiCare™, a nasal steroid spray for allergenic and non-allergenic rhinitis (hay fever / stuffy nose). The manufacturer filed an Abbreviated New Drug Application (ANDA) with the FDA at the end of 2014, and an approval of would enable Innovus to market FlutiCare™ over-the-counter (OTC) possibly as soon the end of 2016 / early 2017. Innovus sees a positive FlutiCare™ decision as having transformative potential for the company. Indeed, if approved, FlutiCare would represent the company’s largest market opportunity; management estimates the addressable market for FlutiCare™ OTC commercial products as much as $1 billion per year, which does not seem too aggressive considering 40mn doses were dispensed in 2014.

Health and Vitality portfolio has large potential

Beyond FlutiCare™ Innovus is also already targeting several large OTC markets for health and vitality, which the company estimates represent a multi-billion dollar opportunity. These include female sexual arousal / satisfaction oil Zestra® and products for Premature Ejaculation / Penile Sensitivity. Management believes it has products that target a billion-dollar plus market opportunity in both men’s and women’s health / vitality. Indeed the company appears to be making progress in the early stages of commercialization, given that Innovus has stated that it has signed eight commercial partnerships with over $500mn in sales milestones plus royalties, in 60 countries.

Innovus price target increased to $0.91

We see Innovus as a high-risk / high-reward investment opportunity in the OTC pharmaceuticals space with a differentiated business model focused on men and women’s health and vitality. We are enthused by the growth and synergies enabled by the Beyond Human acquisition, and eager to learn of the upcoming FDA decision for FlutiCare™.

Please review important disclosures at www.seethruequity.com.

About Innovus Pharmaceuticals, Inc.

Headquartered in San Diego, Innovus Pharma is an emerging leader in OTC and consumer products for men’s and women’s health and vitality. The Company generates revenues from its lead products (a) BTH® Testosterone Booster, (b) BTH® Human Growth Agent, (c) Zestra® for female arousal and (d) EjectDelay® for premature ejaculation and has an additional five marketed products in this space, including (e) Sensum+® for the indication of reduced penile sensitivity, (for sales outside the U.S. only), (f) Zestra Glide®, (g)Vesele® for promoting sexual and cognitive health, (i) Androferti® (in the US and Canada) to support overall male reproductive health and sperm quality, (j) BTH Vision Formula, (k) BTH Blood Sugar, among others and eventually FlutiCare™ OTC for Allergic Rhinitis, if its ANDA is approved by the U.S. FDA.

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. The company does not conduct any investment banking or commission based business. SeeThruEquity is approved to contribute its research to Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks, and distribute its research to its database of opt-in investors. The company also contributes its estimates to Thomson Estimates, the leading estimates platform on Wall Street.

For more information visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 440300

• $50 Million New Age Beverage Business Combined With Búcha, Inc. Provides Scale Platform in the Fast Growing Healthy Functional Beverage Segment
• Additions of Xingtea®, Xingenergy® and Aspen Pure® Brands to Búcha® Live Kombucha Brand Create Complimentary Portfolio in Attractive Segments
• Combines Sales and Distribution Capabilities and Infrastructures of New Age and Búcha, Inc. To Capture >$7.5 Million in Cost and Revenue Synergies

TORRANCE, CA / ACCESSWIRE / May 23, 2016 / Búcha, Inc. (formerly American Brewing) (OTC: ABRW), the California-based owner of the Búcha® Live Kombucha brand, and the New Age Beverages Group, a Colorado-based, leading all-natural tea and other healthy beverage company today announced the signing of a definitive agreement to merge the two companies and create an industry leading healthy functional beverage company. The combination with Búcha significantly augments the Company’s scale, strengthens the infrastructure and leadership team, and accelerates the sales and distribution capabilities of the firm, leading to cost and revenue synergies in excess of $7.5 million.

THE TRANSACTION:

The transaction includes a combination of cash and equity totaling $19,995,000 in return for 100% of the assets and interests of New Age Beverages including their brands XingTea®, XingEnergy®, and Aspen Pure®. The consideration includes an initial $8.5 million cash payment to the majority owner of the firm that will be paid at closing, and an issuance of common stock in Búcha, Inc. (ABRW) to the Executives and the majority owner totaling $6,995,000. The total amount of shares will be based on the Volume Weighted Average Price (“VWAP”) for the thirty days prior to closing. Finally, there is a promissory note for a deferred payment to the majority owner for $4.5 million in cash. Six months after closing, a 1% interest rate on any outstanding principal will be incurred until paid in full.

The initial cash payment of $8.5 million will be financed via debt from one of a number of sources that have committed to provide funding at attractive rates. The transaction is expected to close on or about June 30, 2016. Post-closing, there is expected to be around 25 million shares outstanding on a fully diluted basis. The number of shares will fluctuate as the final total amount of common stock to be issued is based on the 30-day VWAP prior to closing.

NEW AGE BEVERAGE GROUP:

New Age Beverages is a highly profitable, >$50 million privately-owned firm based in Denver, Colorado with leading brands in the Ready-to-Drink (RTD) Tea segment and Functional Waters. The Company was founded by Scott and Tom Lebon, who will continue as President and Senior Vice-President of Sales of the new Company. Scott and Tom created XingTea®, an all-natural RTD Tea made with pure cane sugar, that is the Company’s flagship brand. XingTea® is distributed in major national retailers across 46 states and in 10 countries around the world. The Company recently extended the Xing brand with XingJuice®, and XingEnergy® launched in May 2016. Aspen Pure® is the Company’s Functional Water brand made from pure artesian source water in the Colorado Rocky Mountains. The Company also has a major direct store distribution (DSD) division and is the largest independent beverage distributor in Colorado and surrounding areas, directly serving more than 4,500 outlets.

BUILDING A LEADING HEALTHY FUNCTIONAL BEVERAGE COMPANY:

The new company will own outstanding growth brands in some of the fastest growing segments of the beverage industry. The group will possess the leading brands of Búcha® Live Kombucha, in the rapidly growing Kombucha category, XingTea® in the RTD Tea category, the new XingEnergy® in Energy Drinks, and Aspen Pure® in Functional Waters. The Kombucha category is a $529 million segment growing at around 40% per year. RTD tea is now a $6.6 billion category in the US alone growing at 3.6%, and Functional Waters is a $17.2 billion segment growing at 11.5% per year. This compares to Carbonated Soft Drinks, for example, that is declining around 2% per year and has declined for 11 straight years in the US.

The newly combined entity will be renamed the New Age Beverages Corporation and will be based out of Denver, Colorado. The group will focus on sales, marketing, and distribution and will continue to utilize its national outsourced manufacturing network. It expects significant organic growth via distribution, and to add other healthy functional beverages to the portfolio.

Brent David Willis, who will be the Chief Executive Officer of the combined company, commented, “The combination of New Age and Búcha creates a credible platform to compete against the traditional large beverage companies. I am excited to lead the new company together with Scott and Tom, who I have known for a long period of time. They are very well respected in the industry and I am confident that we will be highly complementary in what we bring to the new operation. We will have the scale and capabilities to effectively compete, and will provide a one-stop-shop for retailers with excellent growth brands that meet consumer’s needs for healthier alternatives.”

BÚCHA, INC:

Búcha, Inc. is one of the leaders in the rapidly growing Kombucha category. The Búcha® Live Kombucha brand is one of the fastest growing brands in the segment. It was recently named as a breakout brand for 2016 by the Hartman Group because of its 353% growth 2012-2015, and its mainstream appealing flavor profile. Búcha, Inc. is the new name of the American Brewing Company, an award winning craft brewery that was founded by Neil Fallon, who will continue as Chairman of the new Company. The brewery was recently sold to enable the acquisition of Búcha® in mid-2015 and establish the platform as a healthy functional beverage company.

Mr. Fallon commented, “I am extremely pleased with the rapid evolution of our firm, and see great potential for the new Company to drive significant shareholder value. The leadership team at New Age is outstanding and driving Búcha® through their distribution and Xing® in ours will significantly accelerate the trajectory of the both firms.”

CAPTURING SIGNIFICANT COST AND REVENUE SYNERGIES:

As part of the combination, the team has identified more than $7.5 Million in cost and revenue synergies to be gained over the next 12 to 18 months. A convergence committee has been established that begins work immediately on the identified areas of savings and growth spanning culture, cost efficiency, and sales, distribution and marketing. In the cost synergy area, the group will realize more than $1 million in immediate savings in operating expenses and infrastructure convergence. The group is expected to operate with significant lower financing and interest expenses, and achieve significant operational efficiencies in sourcing, production and shipping which will have a material impact on gross margin. New Age Beverages on its own generated more than $3 million in free cash flow in 2015, and the combined group is expected to significantly add to this as the cost synergies are achieved and flow through to the bottom line.

In revenue synergies, the group intends to expand XingTea® into Búcha’s food, drug, and mass customers and similarly expects to expand the Búcha® Live Kombucha brand into XingTea’s food, drug, and mass customers. The group will also expand Búcha® into New Age’s captive DSD distribution system that covers 4,500 outlets. Búcha® currently generates an average of around $2,000 in revenue per outlet annually, so as this synergy materializes it will have a significant impact on top-line growth.

Scott Lebon, President of the newly combined group commented, “I am very excited with this new partnership that will provide us the resources to significantly expand XingTea’s presence with retailers and consumers. We know we have a great and preferred brand in the category that we will now be able to grow along with Búcha® Live Kombucha, in the exciting Kombucha space, our new XingEnergy®, and our Aspen Pure® brand in the Functional Water segment. With this new structure and together with Brent and his background, I see nothing that can stop us from becoming the largest healthy functional beverage company in the world.”

About Búcha, Inc. (OTC: ABRW):

Based in Torrance, California, Búcha, Inc. was created in May 2016. It was originally founded as two separate companies in 2010, American Brewing and B&R Liquid Adventure. In 2014 American Brewing became a public company trading under the symbol ABRW, and in 2015, the Company acquired 100% of the assets of Búcha® Live Kombucha from B&R. American Brewing then sold their brewing assets to focus on the new business. The Company is the owner of the Búcha® Live Kombucha brand, one of the fastest growing and leading brands in the rapidly growing Kombucha (fermented tea) category. The Company’s website is www.mybucha.com.

Safe Harbor Disclosure:

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management’s current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company including statements regarding American Brewing’s expectation to see continued growth. The forward-looking statements are based on the assumption that operating performance and results will continue in line with historical results. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. American Brewing competes in a rapidly growing and transforming industry, and other factors disclosed in the Company’s filings with the Securities and Exchange Commission might affect the Company’s operations. Unless required by applicable law, ABRW undertakes no obligation to update or revise any forward-looking statements.

For investor inquiries please contact:

Julie Anderson
Julie@americanbrewing.com
Website: www.mybucha.com

SOURCE: Búcha, Inc.

ReleaseID: 440281

Bullet Proof Your Backpack, Briefcase or Laptop Bag with a Lightweight Removable Ballistic Panel

HOUSTON, TX / ACCESSWIRE / May 23, 2016 / TuffyPacks, LLC has released 3 Personal Ballistic Shields designed to turn everyday backpacks and laptop bags into bulletproof personal protection devices.

“With the global increase of active shooter incidents occurring at schools and in the workplace globally, we felt the need was overdue to provide a defensive solution in the event of an active shooter incident,” stated Steve Naremore, CEO of www.TuffyPacks.com.

TuffyPacks manufactures global defensive solutions to the ever increasing problem of active shooter incidents. They offer a line custom backpack inserts that provide a level of personal protection from ballistic threats, similar to what law enforcement officers wear daily as bullet proof vests. The TuffyPacks, LLC Ballistic Shields® conform to the National Institute of Justice (NIJ) Level IIIA threat requirements.

Unlike a vest, which is designed to be worn, TuffyPacks ballistic shields, when inserted into backpacks, briefcases, purses, or computer bags, will provide the highest level of protection currently available as lightweight concealable body armor. Backpacks with ballistic protection weigh only 16 – 24 ounces more than a non-protected pack (based on the pack size). Additionally, the ballistic shields are removable when the user feels the environment they’re in is non-threatening.

Tuffy Ballistic Shields will stop what is referred to as a Level lll A threat, protecting the user against most handguns and semi-automatic rounds. This is protection includes 44 Magnums, Semi Jacketed Hollow Point (SJHP) bullets and 9mm full-metal jacketed bullets up to (124 gr.) impacting at a velocity 1400 ft/s or less.

The 3 shields just released on www.TuffyPacks.com include a 12″ x 18″ for adult packs, 12″ x 16″, for youth packs and an 11″ x 14″ shield for laptop bags, tote bags or briefcases.

Contact:

Steven Naremore, CEO
832-643-7071
stevenaremore@yahoo.com

Full press photo panel available upon request.

SOURCE: TuffyPacks, LLC

ReleaseID: 440280